Authors showed that post-stroke intracerebroventricular injection of CD200 (as an agonist of CD200R) improved sensorimotor function in a battery of behavioral tests: Longa test, adhesive removal test, limb-use asymmetry test and the modified grip-traction test. Here, CD200R1 is linked to stroke disorder.